Variant report
Variant | esv3513583 |
---|---|
Chromosome Location | chr11:58593026-58597124 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573653548 | chr11:58593057-58593058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527739451 | chr11:58593112-58593113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11229647 | chr11:58593128-58593129 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs199603812 | chr11:58593132-58593133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567315381 | chr11:58593138-58593139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12278955 | chr11:58593173-58593174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538021670 | chr11:58593182-58593183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190007772 | chr11:58593187-58593188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558883137 | chr11:58593363-58593364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371065366 | chr11:58593376-58593377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553235167 | chr11:58593414-58593415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545380580 | chr11:58593415-58593416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1943275 | chr11:58593419-58593420 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs538591506 | chr11:58593422-58593423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542697732 | chr11:58593424-58593425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371419929 | chr11:58593510-58593511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373695194 | chr11:58593571-58593572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553305063 | chr11:58593576-58593577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182593608 | chr11:58593606-58593607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542279435 | chr11:58593696-58593697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188221190 | chr11:58593716-58593717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576086088 | chr11:58593719-58593720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1943276 | chr11:58593748-58593749 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs562981060 | chr11:58593752-58593753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533674146 | chr11:58593782-58593783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371510885 | chr11:58593806-58593807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560480941 | chr11:58593848-58593849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs193159802 | chr11:58593872-58593873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549424717 | chr11:58593876-58593877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567731565 | chr11:58593907-58593908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369303742 | chr11:58593908-58593909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200052228 | chr11:58593910-58593911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs80184726 | chr11:58593911-58593912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531750728 | chr11:58593917-58593918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549942682 | chr11:58593929-58593930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145424476 | chr11:58594003-58594004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77313184 | chr11:58594049-58594050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543913631 | chr11:58594055-58594056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185359239 | chr11:58594074-58594075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565307110 | chr11:58594081-58594082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113645762 | chr11:58594134-58594135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554304078 | chr11:58594157-58594158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140340861 | chr11:58594189-58594190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114785255 | chr11:58594192-58594193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576078495 | chr11:58594194-58594195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189021818 | chr11:58594229-58594230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556674542 | chr11:58594230-58594231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192624344 | chr11:58594232-58594233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147698834 | chr11:58594266-58594267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142323626 | chr11:58594276-58594277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:58593000-58596600 | Weak transcription | HMEC | breast |
2 | chr11:58593200-58596600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr11:58595600-58598600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr11:58596600-58597800 | Enhancers | HMEC | breast |
5 | chr11:58596600-58597800 | Enhancers | NHEK | skin |
6 | chr11:58596600-58598000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr11:58596600-58598000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr11:58596600-58598000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr11:58596800-58604200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |